Report cover image

Global Tissue and Organ Transplantation Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 194 Pages
SKU # APRC20361586

Description

Summary

According to APO Research, The global Tissue and Organ Transplantation market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Tissue and Organ Transplantation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Tissue and Organ Transplantation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Tissue and Organ Transplantation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Tissue and Organ Transplantation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Tissue and Organ Transplantation include Arthrex, Biolife Solutions, Discovery Life Sciences, Medtronic, Stryker Corporation, Teva Pharmaceuticals, Veloxis Pharmaceutical, Zimmer Biomet and Abbvie, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Tissue and Organ Transplantation, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Tissue and Organ Transplantation, also provides the revenue of main regions and countries. Of the upcoming market potential for Tissue and Organ Transplantation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tissue and Organ Transplantation revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Tissue and Organ Transplantation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Tissue and Organ Transplantation revenue, projected growth trends, production technology, application and end-user industry.

Tissue and Organ Transplantation Segment by Company

Arthrex
Biolife Solutions
Discovery Life Sciences
Medtronic
Stryker Corporation
Teva Pharmaceuticals
Veloxis Pharmaceutical
Zimmer Biomet
Abbvie
Novartis
Tissue and Organ Transplantation Segment by Type

Preservation Solution
Immunosuppressive Drugs
Tissue Products
Tissue and Organ Transplantation Segment by Application

Hospital
Transplant Centers
Others
Tissue and Organ Transplantation Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue and Organ Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tissue and Organ Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue and Organ Transplantation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Tissue and Organ Transplantation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Tissue and Organ Transplantation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tissue and Organ Transplantation revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Tissue and Organ Transplantation Market by Type
1.2.1 Global Tissue and Organ Transplantation Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Preservation Solution
1.2.3 Immunosuppressive Drugs
1.2.4 Tissue Products
1.3 Tissue and Organ Transplantation Market by Application
1.3.1 Global Tissue and Organ Transplantation Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Transplant Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Tissue and Organ Transplantation Market Dynamics
2.1 Tissue and Organ Transplantation Industry Trends
2.2 Tissue and Organ Transplantation Industry Drivers
2.3 Tissue and Organ Transplantation Industry Opportunities and Challenges
2.4 Tissue and Organ Transplantation Industry Restraints
3 Global Growth Perspective
3.1 Global Tissue and Organ Transplantation Market Perspective (2020-2031)
3.2 Global Tissue and Organ Transplantation Growth Trends by Region
3.2.1 Global Tissue and Organ Transplantation Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Tissue and Organ Transplantation Market Size by Region (2020-2025)
3.2.3 Global Tissue and Organ Transplantation Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Tissue and Organ Transplantation Revenue by Players
4.1.1 Global Tissue and Organ Transplantation Revenue by Players (2020-2025)
4.1.2 Global Tissue and Organ Transplantation Revenue Market Share by Players (2020-2025)
4.1.3 Global Tissue and Organ Transplantation Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Tissue and Organ Transplantation Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Tissue and Organ Transplantation Key Players Headquarters & Area Served
4.4 Global Tissue and Organ Transplantation Players, Product Type & Application
4.5 Global Tissue and Organ Transplantation Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Tissue and Organ Transplantation Market CR5 and HHI
4.6.3 2024 Tissue and Organ Transplantation Tier 1, Tier 2, and Tier 3
5 Tissue and Organ Transplantation Market Size by Type
5.1 Global Tissue and Organ Transplantation Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Tissue and Organ Transplantation Revenue by Type (2020-2031)
5.3 Global Tissue and Organ Transplantation Revenue Market Share by Type (2020-2031)
6 Tissue and Organ Transplantation Market Size by Application
6.1 Global Tissue and Organ Transplantation Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Tissue and Organ Transplantation Revenue by Application (2020-2031)
6.3 Global Tissue and Organ Transplantation Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Arthrex
7.1.1 Arthrex Comapny Information
7.1.2 Arthrex Business Overview
7.1.3 Arthrex Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.1.4 Arthrex Tissue and Organ Transplantation Product Portfolio
7.1.5 Arthrex Recent Developments
7.2 Biolife Solutions
7.2.1 Biolife Solutions Comapny Information
7.2.2 Biolife Solutions Business Overview
7.2.3 Biolife Solutions Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.2.4 Biolife Solutions Tissue and Organ Transplantation Product Portfolio
7.2.5 Biolife Solutions Recent Developments
7.3 Discovery Life Sciences
7.3.1 Discovery Life Sciences Comapny Information
7.3.2 Discovery Life Sciences Business Overview
7.3.3 Discovery Life Sciences Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.3.4 Discovery Life Sciences Tissue and Organ Transplantation Product Portfolio
7.3.5 Discovery Life Sciences Recent Developments
7.4 Medtronic
7.4.1 Medtronic Comapny Information
7.4.2 Medtronic Business Overview
7.4.3 Medtronic Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.4.4 Medtronic Tissue and Organ Transplantation Product Portfolio
7.4.5 Medtronic Recent Developments
7.5 Stryker Corporation
7.5.1 Stryker Corporation Comapny Information
7.5.2 Stryker Corporation Business Overview
7.5.3 Stryker Corporation Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.5.4 Stryker Corporation Tissue and Organ Transplantation Product Portfolio
7.5.5 Stryker Corporation Recent Developments
7.6 Teva Pharmaceuticals
7.6.1 Teva Pharmaceuticals Comapny Information
7.6.2 Teva Pharmaceuticals Business Overview
7.6.3 Teva Pharmaceuticals Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.6.4 Teva Pharmaceuticals Tissue and Organ Transplantation Product Portfolio
7.6.5 Teva Pharmaceuticals Recent Developments
7.7 Veloxis Pharmaceutical
7.7.1 Veloxis Pharmaceutical Comapny Information
7.7.2 Veloxis Pharmaceutical Business Overview
7.7.3 Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.7.4 Veloxis Pharmaceutical Tissue and Organ Transplantation Product Portfolio
7.7.5 Veloxis Pharmaceutical Recent Developments
7.8 Zimmer Biomet
7.8.1 Zimmer Biomet Comapny Information
7.8.2 Zimmer Biomet Business Overview
7.8.3 Zimmer Biomet Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.8.4 Zimmer Biomet Tissue and Organ Transplantation Product Portfolio
7.8.5 Zimmer Biomet Recent Developments
7.9 Abbvie
7.9.1 Abbvie Comapny Information
7.9.2 Abbvie Business Overview
7.9.3 Abbvie Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.9.4 Abbvie Tissue and Organ Transplantation Product Portfolio
7.9.5 Abbvie Recent Developments
7.10 Novartis
7.10.1 Novartis Comapny Information
7.10.2 Novartis Business Overview
7.10.3 Novartis Tissue and Organ Transplantation Revenue and Gross Margin (2020-2025)
7.10.4 Novartis Tissue and Organ Transplantation Product Portfolio
7.10.5 Novartis Recent Developments
8 North America
8.1 North America Tissue and Organ Transplantation Revenue (2020-2031)
8.2 North America Tissue and Organ Transplantation Revenue by Type (2020-2031)
8.2.1 North America Tissue and Organ Transplantation Revenue by Type (2020-2025)
8.2.2 North America Tissue and Organ Transplantation Revenue by Type (2026-2031)
8.3 North America Tissue and Organ Transplantation Revenue Share by Type (2020-2031)
8.4 North America Tissue and Organ Transplantation Revenue by Application (2020-2031)
8.4.1 North America Tissue and Organ Transplantation Revenue by Application (2020-2025)
8.4.2 North America Tissue and Organ Transplantation Revenue by Application (2026-2031)
8.5 North America Tissue and Organ Transplantation Revenue Share by Application (2020-2031)
8.6 North America Tissue and Organ Transplantation Revenue by Country
8.6.1 North America Tissue and Organ Transplantation Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Tissue and Organ Transplantation Revenue by Country (2020-2025)
8.6.3 North America Tissue and Organ Transplantation Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Tissue and Organ Transplantation Revenue (2020-2031)
9.2 Europe Tissue and Organ Transplantation Revenue by Type (2020-2031)
9.2.1 Europe Tissue and Organ Transplantation Revenue by Type (2020-2025)
9.2.2 Europe Tissue and Organ Transplantation Revenue by Type (2026-2031)
9.3 Europe Tissue and Organ Transplantation Revenue Share by Type (2020-2031)
9.4 Europe Tissue and Organ Transplantation Revenue by Application (2020-2031)
9.4.1 Europe Tissue and Organ Transplantation Revenue by Application (2020-2025)
9.4.2 Europe Tissue and Organ Transplantation Revenue by Application (2026-2031)
9.5 Europe Tissue and Organ Transplantation Revenue Share by Application (2020-2031)
9.6 Europe Tissue and Organ Transplantation Revenue by Country
9.6.1 Europe Tissue and Organ Transplantation Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Tissue and Organ Transplantation Revenue by Country (2020-2025)
9.6.3 Europe Tissue and Organ Transplantation Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Tissue and Organ Transplantation Revenue (2020-2031)
10.2 China Tissue and Organ Transplantation Revenue by Type (2020-2031)
10.2.1 China Tissue and Organ Transplantation Revenue by Type (2020-2025)
10.2.2 China Tissue and Organ Transplantation Revenue by Type (2026-2031)
10.3 China Tissue and Organ Transplantation Revenue Share by Type (2020-2031)
10.4 China Tissue and Organ Transplantation Revenue by Application (2020-2031)
10.4.1 China Tissue and Organ Transplantation Revenue by Application (2020-2025)
10.4.2 China Tissue and Organ Transplantation Revenue by Application (2026-2031)
10.5 China Tissue and Organ Transplantation Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Tissue and Organ Transplantation Revenue (2020-2031)
11.2 Asia Tissue and Organ Transplantation Revenue by Type (2020-2031)
11.2.1 Asia Tissue and Organ Transplantation Revenue by Type (2020-2025)
11.2.2 Asia Tissue and Organ Transplantation Revenue by Type (2026-2031)
11.3 Asia Tissue and Organ Transplantation Revenue Share by Type (2020-2031)
11.4 Asia Tissue and Organ Transplantation Revenue by Application (2020-2031)
11.4.1 Asia Tissue and Organ Transplantation Revenue by Application (2020-2025)
11.4.2 Asia Tissue and Organ Transplantation Revenue by Application (2026-2031)
11.5 Asia Tissue and Organ Transplantation Revenue Share by Application (2020-2031)
11.6 Asia Tissue and Organ Transplantation Revenue by Country
11.6.1 Asia Tissue and Organ Transplantation Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Tissue and Organ Transplantation Revenue by Country (2020-2025)
11.6.3 Asia Tissue and Organ Transplantation Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Tissue and Organ Transplantation Revenue (2020-2031)
12.2 SAMEA Tissue and Organ Transplantation Revenue by Type (2020-2031)
12.2.1 SAMEA Tissue and Organ Transplantation Revenue by Type (2020-2025)
12.2.2 SAMEA Tissue and Organ Transplantation Revenue by Type (2026-2031)
12.3 SAMEA Tissue and Organ Transplantation Revenue Share by Type (2020-2031)
12.4 SAMEA Tissue and Organ Transplantation Revenue by Application (2020-2031)
12.4.1 SAMEA Tissue and Organ Transplantation Revenue by Application (2020-2025)
12.4.2 SAMEA Tissue and Organ Transplantation Revenue by Application (2026-2031)
12.5 SAMEA Tissue and Organ Transplantation Revenue Share by Application (2020-2031)
12.6 SAMEA Tissue and Organ Transplantation Revenue by Country
12.6.1 SAMEA Tissue and Organ Transplantation Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Tissue and Organ Transplantation Revenue by Country (2020-2025)
12.6.3 SAMEA Tissue and Organ Transplantation Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.